Metformin: repurposing opportunities for cognitive and mood dysfunction.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  CNS and Neurological Disorders - Drug Targets

• Publication date

  2015-01-22

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.2174/1871527313666141130205514PMID 25470390
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cognition and behavior

  2015cited by this paper
• Diabetes Mellitus and Disturbances in Brain Connectivity: A Bidirectional Relationship?

  2014cited by this paper
• Insulin Action in Brain Regulates Systemic Metabolism and Brain Function

  2014cited by this paper
• Insulin protects against Aβ-induced spatial memory impairment, hippocampal apoptosis and MAPKs signaling disruption.

  2014cited by this paper
• Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats.

  2014cited by this paper
• Effects of Metformin on the Cerebral Metabolic Changes in Type 2 Diabetic Patients

  2014cited by this paper
• Insulin inhibits Abeta production through modulation of APP processing in a cellular model of Alzheimer's disease.

  2014cited by this paper
• Deregulation of brain insulin signaling in Alzheimer’s disease

  2014cited by this paper
• Epilepsy, Cognition and Behavior

  2014cited by this paper
• Effect of metformin on methylglyoxal metabolism in patients with type 2 diabetes.

  2014cited by this paper
• Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice.

  2014cited by this paper
• The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex

  2014cited by this paper
• Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice.

  2014cited by this paper
• The therapy of insulin resistance in other diseases besides type 2 diabetes

  2014cited by this paper
• Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes

  2014cited by this paper
• Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre‐activation of AMPK‐dependent autophagy

  2014cited by this paper
• Impaired mitochondrial respiration promotes dendritic branching via the AMPK signaling pathway

  2014cited by this paper
• DTI Correlates of Cognition in Conventional MRI of Normal-Appearing Brain in Patients with Clinical Features of Subacute Combined Degeneration and Biochemically Proven Vitamin B12 Deficiency

  2014cited by this paper
• Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

  2014cited by this paper
• Novel action of metformin in the prevention of haloperidol-induced catalepsy in mice: Potential in the treatment of Parkinson's disease?

  2014cited by this paper
• Methylglyoxal impairs endothelial insulin sensitivity both in vitro and in vivo

  2014cited by this paper
• Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus

  2014cited by this paper
• Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK)*♦

  2014cited by this paper
• Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice.

  2014cited by this paper
• The management of patients with polycystic ovary syndrome

  2014cited by this paper
• Increased plasma levels of the methylglyoxal in patients with newly diagnosed type 2 diabetes 初诊2型糖尿病患者血浆甲基乙二醛水平升高

  2014cited by this paper
• Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial.

  2013cited by this paper
• Grape powder supplementation prevents oxidative stress-induced anxiety-like behavior, memory impairment, and high blood pressure in rats.

  2013cited by this paper
• Vitamin B12 deficiency and the lack of its consequences in type 2 diabetes patients using metformin.

  2013cited by this paper
• Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin

  2013cited by this paper
• Comparative effects of pioglitazone and metformin on oxidative stress markers in newly diagnosed type 2 diabetes patients: a randomized clinical trial.

  2013cited by this paper
• Restoration of glyoxalase enzyme activity precludes cognitive dysfunction in a mouse model of Alzheimer's disease.

  2013cited by this paper
• Metabolic syndrome and major depression

  2013cited by this paper
• The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation.

  2013cited by this paper
• Metformin Down-regulates TNF-α Secretion via Suppression of Scavenger Receptors in Macrophages

  2013cited by this paper
• Metformin improves healthspan and lifespan in mice

  2013cited by this paper
• Serum vitamin B12 not reflecting vitamin B12 status in patients with type 2 diabetes.

  2013cited by this paper
• Methylglyoxal, cognitive function and cerebral atrophy in older people.

  2013cited by this paper
• COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONS

  2013cited by this paper
• Intracellular cytokine production and cognition in healthy older adults.

  2013cited by this paper
• Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation.

  2012cited by this paper
• Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice.

  2012cited by this paper
• Methylglyoxal Induces Tau Hyperphosphorylation via Promoting AGEs Formation

  2012cited by this paper
• Cognitive impairment and vitamin B12: a review

  2012cited by this paper
• Cellular and molecular mechanisms of metformin: an overview.

  2012cited by this paper
• Miglitol, an anti-diabetic drug, inhibits oxidative stress-induced apoptosis and mitochondrial ROS over-production in endothelial cells by enhancement of AMP-activated protein kinase.

  2012cited by this paper
• Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights

  2012cited by this paper
• Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

  2012cited by this paper
• A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin

  2012cited by this paper
• Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats.

  2012cited by this paper
• Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study

  2012cited by this paper
• Possible link between the cognitive dysfunction associated with diabetes mellitus and the neurotoxicity of methylglyoxal.

  2012cited by this paper
• Glyoxalase in diabetes, obesity and related disorders.

  2011cited by this paper
• AMP-activated protein kinase (AMPK) activity is not required for neuronal development but regulates axogenesis during metabolic stress

  2011cited by this paper
• Reduced Cell Proliferation and Neuroblast Differentiation in the Dentate Gyrus of High Fat Diet-Fed Mice are Ameliorated by Metformin and Glimepiride Treatment

  2011cited by this paper
• AMP-Activated Protein Kinase Regulates Neuronal Polarization by Interfering with PI 3-Kinase Localization

  2011cited by this paper
• Role of the Glyoxalase System in Astrocyte-Mediated Neuroprotection

  2011cited by this paper
• AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function.

  2011cited by this paper
• Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis.

  2010cited by this paper
• Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

  2010cited by this paper
• Rosiglitazone and Cognitive Stability in Older Individuals With Type 2 Diabetes and Mild Cognitive Impairment

  2010cited by this paper
• Metabolic Regulation of Neuronal Plasticity by the Energy Sensor AMPK

  2010cited by this paper
• Copyright © 2010 by Institute of Pharmacology Polish Academy of Sciences

  2010cited by this paper
• Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling

  2010cited by this paper
• Metformin Normalizes Type 2 Diabetes-Induced Decrease in Cell Proliferation and Neuroblast Differentiation in the Rat Dentate Gyrus

  2010cited by this paper
• Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide

  2010cited by this paper
• Association between folate, vitamin B(6) and vitamin B(12) intake and depression in the SUN cohort study.

  2009cited by this paper
• Cytoprotective mechanisms of carbonyl scavenging drugs in isolated rat hepatocytes.

  2009cited by this paper
• Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription

  2009cited by this paper
• Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism.

  2009cited by this paper
• Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes.

  2008cited by this paper
• Reduced expression of glyoxalase-1 mRNA in mood disorder patients.

  2008cited by this paper
• Methylglyoxal causes strong weakening of detoxifying capacity and apoptotic cell death in rat hippocampal neurons.

  2008cited by this paper
• LKB1 and AMPK in cell polarity and division.

  2008cited by this paper
• Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels.

  2008cited by this paper
• Increased risk of depressive disorders in women with polycystic ovary syndrome.

  2007cited by this paper
• Neuroprotective Role of Antidiabetic Drug Metformin Against Apoptotic Cell Death in Primary Cortical Neurons

  2007cited by this paper
• Metformin prevents methylglyoxal-induced apoptosis of mouse Schwann cells.

  2007cited by this paper
• Risk factors of vitamin B(12) deficiency in patients receiving metformin.

  2006cited by this paper
• Molecular mechanisms of insulin resistance in polycystic ovary syndrome.

  2006cited by this paper
• Dicarbonyl Intermediates in the Maillard Reaction

  2005cited by this paper
• Methylglyoxal, Glyoxal, and Their Detoxification in Alzheimer's Disease

  2005cited by this paper
• Reactive oxygen species and synaptic plasticity in the aging hippocampus.

  2004cited by this paper
• A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects.

  2004cited by this paper
• Insights into the ageing mind: a view from cognitive neuroscience

  2004cited by this paper
• The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism.

  2002cited by this paper
• Role of AMP-activated protein kinase in mechanism of metformin action.

  2001cited by this paper
• Role of insulin and insulin receptor in learning and memory.

  2001cited by this paper
• Cytokines and the brain: implications for clinical psychiatry.

  2000cited by this paper
• Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I*

  2000cited by this paper
• Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin.

  2000cited by this paper
• Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.

  2000cited by this paper
• Metformin reduces systemic methylglyoxal levels in type 2 diabetes.

  1999cited by this paper
• Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain.

  1996cited by this paper
• Early increases in TNF-α, IL-6 and IL-1β levels following transient cerebral ischemia in gerbil brain

  1996cited by this paper
• Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor Statil.

  1993cited by this paper

• Syringic acid loaded chitosan nanoparticles mitigate glycation associated oxidative stress and inflammation in hyperglycaemic rat model

  2025cites this paper
• Metformin for neurocognitive dysfunction in schizophrenia: a systematic review

  2025cites this paper
• Exploring the clinical connections between epilepsy and diabetes mellitus: Promising therapeutic strategies utilizing agmatine and metformin

  2024cites this paper
• Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism

  2023influential citation
• Metformin mitigates amyloid β1-40-induced cognitive decline via attenuation of oxidative/nitrosative stress and neuroinflammation

  2023cites this paper
• Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations

  2023cites this paper
• Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis

  2023cites this paper
• Unveiling new secrets in Parkinson's disease: the glycatome.

  2023cites this paper
• Type 2 Diabetes Mellitus-associated Cognitive Dysfunction: Advances in Potential Mechanisms and Therapies.

  2022cites this paper
• Interactive relationships of Type 2 diabetes and bipolar disorder with cognition: evidence of putative premature cognitive ageing in the UK Biobank Cohort

  2022cites this paper
• Drug repurposing candidates to treat core symptoms in autism spectrum disorder

  2022cites this paper
• Effect of metformin on intact mitochondria from liver and brain: Concept revisited.

  2022cites this paper
• Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin

  2022cites this paper
• Candidates for Drug Repurposing to Address the Cognitive Symptoms in Schizophrenia

  2022cites this paper
• Metformin Treatment Attenuates Brain Inflammation and Rescues PACAP/VIP Neuropeptide Alterations in Mice Fed a High-Fat Diet

  2021cites this paper
• Cognitive Impairment in Frail Hypertensive Elderly Patients: Role of Hyperglycemia

  2021cites this paper
• Insulin resistance is associated with verbal memory impairment in bipolar disorders.

  2020cites this paper
• Metformin Enhances Excitatory Synaptic Transmission onto Hippocampal CA1 Pyramidal Neurons

  2020cites this paper
• Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review

  2020cites this paper
• Metformin and cognition from the perspectives of sex, age, and disease

  2020cites this paper
• Metabolic stress is a primary pathogenic event in transgenic Caenorhabditis elegans expressing pan-neuronal human amyloid beta

  2019cites this paper
• Neuromodulatory effects of anti-diabetes medications: a mechanistic review.

  2019cites this paper
• Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness

  2019cites this paper
• Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism

  2018cites this paper
• Drug repurposing may generate novel approaches to treating depression

  2017cites this paper
• Effects of turmeric curcuminoids and metformin against central sensitivity to pain in mice

  2016cites this paper
• The neurobiology of the Prader-Willi phenotype of fragile X syndrome.

  2016cites this paper
• Cognitive remission: a novel objective for the treatment of major depression?

  2016cites this paper
• Repurposing of Anti-Diabetic Agents for the Treatment of Cognitive Impairment and Mood Disorders.

  2016cites this paper
• Canmetformin Buffer the Deleterious Association between Psychological Distress and Glycemia in Patients with Type 2 Diabetes ?

  2015cites this paper